{"transactions":[{"id":942535,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":69710,"kind":"person","name":"Chen Ruoyu","position":1,"cik":"0001982080","reported_name":"Chen Ruoyu","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-09T21:01:14.000Z","date":"2026-01-07","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 50,000 shares of the Issuer's common stock, 25% of which will vest on January 7, 2027, with the remaining vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":50000,"derivative":{"exercise_price":7.31,"expiration_date":"2036-01-07","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001140361-26-000831","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126000831/form4.xml","form_type":"4"}},{"id":1431650,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":69710,"kind":"person","name":"Chen Ruoyu","position":1,"cik":"0001982080","reported_name":"Chen Ruoyu","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-17T00:53:18.000Z","date":"2024-08-14","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 50,000 shares of the Issuer's common stock, 25% of which will vest on August 14, 2025, with the remaining vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":50000,"derivative":{"exercise_price":9.98,"expiration_date":"2034-08-14","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001140361-24-037706","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036124037706/form4.xml","form_type":"4"}},{"id":1731641,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":69710,"kind":"person","name":"Chen Ruoyu","position":1,"cik":"0001982080","reported_name":"Chen Ruoyu","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-23T00:34:30.000Z","date":"2023-11-20","kind":"grant","planned":false,"acquired":true,"shares":578540,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Beijing Continent Pharmaceuticals Co., Ltd, a company organized under the laws of the People's Republic of China (\"Beijing Continent\"), terminated its 2021 Stock Incentive Plan (the \"2021 Plan\") and each option (a \"BC Option\") to purchase common shares of Beijing Continent outstanding under the 2021 Plan was terminated and replaced with options granted pursuant to a sub-plan for Chinese participants under the Issuer's 2023 Omnibus Incentive Plan that are substantially similar in all material respects to the BC Options previously outstanding under the 2021 Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Beijing Continent Pharmaceuticals Co., Ltd, a company organized under the laws of the People's Republic of China (\"Beijing Continent\"), terminated its 2021 Stock Incentive Plan (the \"2021 Plan\") and each option (a \"BC Option\") to purchase common shares of Beijing Continent outstanding under the 2021 Plan was terminated and replaced with options granted pursuant to a sub-plan for Chinese participants under the Issuer's 2023 Omnibus Incentive Plan that are substantially similar in all material respects to the BC Options previously outstanding under the 2021 Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are vested in full."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Beijing Continent Pharmaceuticals Co., Ltd, a company organized under the laws of the People's Republic of China (\"Beijing Continent\"), terminated its 2021 Stock Incentive Plan (the \"2021 Plan\") and each option (a \"BC Option\") to purchase common shares of Beijing Continent outstanding under the 2021 Plan was terminated and replaced with options granted pursuant to a sub-plan for Chinese participants under the Issuer's 2023 Omnibus Incentive Plan that are substantially similar in all material respects to the BC Options previously outstanding under the 2021 Plan."}],"balance_after":578540,"derivative":{"exercise_price":0.75,"expiration_date":"2030-10-31","underlying":"Common Stock","underlying_shares":578540},"source":{"system":"sec-edgar","filing":"0001140361-23-054516","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036123054516/form4.xml","form_type":"4"}},{"id":1752575,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":69710,"kind":"person","name":"Chen Ruoyu","position":1,"cik":"0001982080","reported_name":"Chen Ruoyu","relationship":{"officer":true,"officer_title":"Interim CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-01T10:15:29.000Z","date":"2023-10-31","kind":"grant","planned":false,"acquired":true,"shares":34380,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options are vested in full."}],"balance_after":34380,"derivative":{"exercise_price":6.93,"expiration_date":"2033-10-31","underlying":"Common Stock","underlying_shares":34380},"source":{"system":"sec-edgar","filing":"0001140361-23-050617","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036123050617/form4.xml","form_type":"4"}}]}